MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer Final LCD - Effective August 24, 2020

This Local Coverage Determination (LCD) has completed the Open Public Meeting and Contractor Advisory Committee (CAC) comment period and is now finalized under contractor numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY). Responses to comments received may be found as a link at the bottom of the final LCD.

Medicare Coverage Database (MCD) Number/Contractor Determination Number: L38329
LCD Title: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
Effective Date: August 24, 2020
Summary of LCD: This policy concerns the use of molecular diagnostic laboratory tests (tests of DNA, RNA, and / or proteins) as a predictive classifier for non-small cell lung cancer (NSCLC) and provides criteria for coverage.

Visit the Future LCDs webpage to access this LCD.

 

            Last Updated Mon, 13 Jul 2020 20:15:05 +0000